There is a low finding rate of newly smear positive TB patients.
新涂阳结核病人发现率较低。
There were 141 smear positive cases, which accounted for 58.8% of active TB cases.
①涂阳病人141例，涂阳占活动性肺结核病人中比例为58.8%；
The curing rate of the smear positive PT patients was high, while the management rate of patients was lower.
涂阳肺结核病人治愈率较高，对病人的督导管理率较低。
The primary outcome measure was the proportion of instructed and non-instructed women testing smear positive.
主要结果评估经指导后以及未进行指导后妇女检测涂片阳性结果。
Objective To evaluate the DOTS effect of new smear positive cases with pulmonary tuberculosis in Baoan District, Shenzhen, 1993 ~ 1999.
目的评价深圳市宝安区1993 ~ 1999年常住、暂住初治涂阳肺结核病人直接督导化疗的转归。
Methods The newly registered smear positive cases with pulmonary tuberculosis including temporary residents in 1993~1999 were supervised.
方法1993～ 1999年门诊登记的初治涂阳包括暂住肺结核病人在内纳入结控项目同步管理。
Objective To explore a dynamic evaluation model for prediction the result of chemotherapy in new smear positive pulmonary tuberculosis cases.
目的探索适宜的初治涂阳肺结核化疗结局的预测模型。
Objective To evaluate 1993-2000 Dalian tuberculosis prevention and treatment result and the trend of drug resistance of the smear positive tuberculosis.
目的评价1993—2 0 0 0年大连市结核病防治效果及结核分支杆菌的耐药率趋势。
Methods 36 423 confirmed close contacts of smear positive cases were asked to provide 3 sputum specimens (night, morning and spot sputum) for smear examination.
方法确认的家庭密切接触者36 423人，每人提供3份痰标本(夜间痰、晨痰和即时痰)，进行痰涂片检查。
Conclusion The work in prevention and treatment of TB has made remarkable achievements. The registered rate of new smear positive pulmonary TB has improved noticeably.
结论结核病防治工作取得显著成绩，新发涂阳发现率有明显提高，圆满完成省级下达的新发涂阳病人发现任务。
Objective To explore the effect of implementing tuberculosis convergence case-management for improving case finding rate and cure rate in smear positive pulmonary tuberculosis.
目的探讨实施结核病归口管理对提高涂阳肺结核病人发现率和治愈率的影响。
Conclusion to do sputum examination in general hospitals is an effective method to increase smear positive case detection rate, especially new smear positive case detection rate.
结论综合性医院开展痰涂片检查是提高涂阳病人发现率，特别是提高新发涂阳病人发现率的有效手段。
Results Comparing with recent decade, the prevalence rate of active tuberculosis and smear positive has been declined 28.8% and 4.5% respectively, and the mortality rate is 73.6% .
结果全省结核病疫情和十年前相比，肺结核病患病率、涂阳患病率、菌阳患病率和死亡率分别下降28.8％、4.5％、8.6％和73.6％。
MethodsThe re-treated smear positive patients with PTB were inquired of the past medical history and the usage of drugs, and were implemented the chemotherapy regimen recommended by WHO.
方法了解复治涂阳患者的既往史及用药史，并按WHO推荐方案进行治疗。
To develop new methods for estimating the sputum smear-positive tuberculosis case detection rate (CDR) in a country where infection with HIV is prevalent.
寻找艾滋病高发国家的痰涂片阳性肺结核检出率的估算新方法。
Through this approach, the project achieved 100% DOTS coverage, 77% case detection and a 92% cure rate for detected TB smear-positive patients.
借助这一疗法，项目下DOTS疗法覆盖率达到了100%，病例发现率达77%，结核病痰涂片呈阳性患者的治愈率达92%。
The separate estimate for all smear-positive tuberculosis cases was 72% (95% CI: 53-91), giving an overall average for the three estimates of 70% (95% CI: 58-82).
单独来看，所有痰涂片阳性肺结核检出率估计为72%(95%的置信区间：53- 91)。三个估值的总平均数为70%(95%的置信区间：58 - 82)。
Sputum test, bacterial culture or both confirmed 269 tuberculosis cases, 174 of which were smear-positive.
痰检查、痰涂片培养或同时进行这两项检查确认了269个结核病例，其中174个病例的涂片呈阳性。
The prevalence rate of smear-positive tuberculosis was 145 per 100 000 (95% confidence interval: 110–180) assuming no tuberculosis in persons aged< 15 years.
如果假设不满15岁的人群中无人罹患结核病，那么痰涂片呈阳性的结核病的患病率为每10万人中有145人（95%的置信区间：110-180）。
Cambodia increased spending, but did not increase the total number of smear-positive patients treated under DOTS.
柬埔寨增加了费用，但是没有增加DOTS所治疗的痰检阳性患者的总数。
Globally, the rate of treatment success for new smear-positive cases treated in DOTS programmes in 2006 reached the target of 85% first set by the WHA in 1991.
2006年DOTS规划中痰涂阳性新病例的治疗成功率达到了1991年世界卫生大会初步确定的85%的目标。
This is equivalent to 1% of the estimated global total of smear-positive cases of MDR-TB.
这相当于痰涂阳性的耐多药结核病例全球估计总数的1%。
Of the additional smear-positive cases reported under DOTS in 2004, three-quarters (75%) were in China, India and Indonesia.
在2004年DOTS报告的痰检阳性增加病例中，四分之三(75%)发生在中国、印度和印度尼西亚。
While WHO measures case detection principally with reference to smear-positive disease, statistics for detection based on other diagnostic methods give a different view of programme performance.
尽管世界卫生组织测量病例检出主要参考痰检阳性病例，但是根据其它诊断方法对病例检出的统计却显示了规划执行的不同情况。
All but one of the 22 HBCs that increased spending between 2003 and 2004 also increased the number of new smear-positive cases that were detected and treated in DOTS programmes.
2003年和2004年之间增加了费用的22个负担沉重国家除了一个之外也增加了DOTS规划发现和治疗的痰检阳性新病例的数量。
The smear-positive case detection rate within established DOTS areas remained stable at an average of 51% up to 2001, but increased to 64% in 2004.
到2001年，已开展DOTS地区内的痰检阳性病例检出率稳定在平均51%的水平，但是2004年却增长至64%。
The outcome targets first set by the World Health Assembly in 1991 are to detect at least 70% of new smear-positive cases in DOTS programmes and to successfully treat at least 85% of detected cases.
1991年世界卫生大会最初规定的结果目标为在DOTS规划中至少检出70%的痰涂阳性新病例并成功地治疗至少85%的检出病例。
Of the additional smear-positive cases reported under DOTS in 2003, 63% were in just two countries: India and China.
在2003年直接督导下的短程化疗报告的痰检阳性增加病例中，63%发生在仅两个国家：印度和中国。
This was 8.5% of the estimated global total of smear-positive cases of MDR-TB.
这仅相当于痰涂阳性耐多药结核病例全球估计总数的8.5%。
This was 8.5% of the estimated global total of smear-positive cases of MDR-TB.
这仅相当于痰涂阳性耐多药结核病例全球估计总数的8.5%。
应用推荐